(Q44639282)

English

Nitric oxide production and regulation of endothelial nitric-oxide synthase phosphorylation by prolonged treatment with troglitazone: evidence for involvement of peroxisome proliferator-activated receptor (PPAR) gamma-dependent and PPARgamma-indepen

scientific article published on 30 October 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 December 2017

Nitric oxide production and regulation of endothelial nitric-oxide synthase phosphorylation by prolonged treatment with troglitazone: evidence for involvement of peroxisome proliferator-activated receptor (PPAR) gamma-dependent and PPARgamma-indepen (English)

1 reference

Europe PubMed Central

4 December 2017

0 references

phosphorylation

1 reference

based on heuristic

inferred from title

author name string

Du-Hyong Cho

1

1 reference

Europe PubMed Central

4 December 2017

Yoon Jung Choi

2

1 reference

Europe PubMed Central

4 December 2017

Sangmee Ahn Jo

3

1 reference

Europe PubMed Central

4 December 2017

Inho Jo

4

1 reference

Europe PubMed Central

4 December 2017

language of work or name

0 references

publication date

30 October 2003

1 reference

Europe PubMed Central

4 December 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

Journal of Biological Chemistry

1 reference

Europe PubMed Central

4 December 2017

279

1 reference

Europe PubMed Central

4 December 2017

2499-2506

1 reference

Europe PubMed Central

4 December 2017

4

1 reference

Europe PubMed Central

4 December 2017

Thiazolidinediones in the treatment of insulin resistance and type II diabetes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. Troglitazone and Exogenous Insulin Study Group.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

Effects of troglitazone: a new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapy.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

Effects of pioglitazone on calcium channels in vascular smooth muscle.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

Troglitazone, but not rosiglitazone, inhibits Na/H exchange activity and proliferation of macrovascular endothelial cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

Reduction of blood pressure, plasma cholesterol, and atherosclerosis by elevated endothelial nitric oxide

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

Inhibiting the NO pathway with intracoronary L-NAME infusion increases endothelial dysfunction and intimal hyperplasia after heart transplantation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

Retinoic acid suppression of endothelial nitric oxide synthase in porcine oocyte

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

Subcellular targeting and agonist-induced site-specific phosphorylation of endothelial nitric-oxide synthase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

Protein-protein interactions controlling nitric oxide synthases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

Dynamic regulation of endothelial nitric oxide synthase: complementary roles of dual acylation and caveolin interactions.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

Reciprocal phosphorylation and regulation of endothelial nitric-oxide synthase in response to bradykinin stimulation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

Regulation of endothelium-derived nitric oxide production by the protein kinase Akt

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

Shear stress stimulates phosphorylation of endothelial nitric-oxide synthase at Ser1179 by Akt-independent mechanisms: role of protein kinase A.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

Rapid increase in endothelial nitric oxide production by bradykinin is mediated by protein kinase A signaling pathway

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

Phosphorylation of Thr(495) regulates Ca(2+)/calmodulin-dependent endothelial nitric oxide synthase activity.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

Dephosphorylation of endothelial nitric-oxide synthase by vascular endothelial growth factor. Implications for the vascular responses to cyclosporin A.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

Identification of regulatory sites of phosphorylation of the bovine endothelial nitric-oxide synthase at serine 617 and serine 635.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K, PKC and PLC pathways

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

Troglitazone inhibits the expression of inducible nitric oxide synthase in adipocytes in vitro and in vivo study in 3T3-L1 cells and Otsuka Long-Evans Tokushima Fatty rats

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

Peroxisome proliferator-activated receptor gamma ligands increase release of nitric oxide from endothelial cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

The oral insulin sensitizer, thiazolidinedione, increases plasma vascular endothelial growth factor in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

Lack of evidence for contribution of Glu298Asp (G894T) polymorphism of endothelial nitric oxide synthase gene to plasma nitric oxide levels

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

Troglitazone treatment increases plasma vascular endothelial growth factor in diabetic patients and its mRNA in 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

A synthetic antagonist for the peroxisome proliferator-activated receptor gamma inhibits adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARgamma

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-gamma

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

Angiogenic actions of angiopoietin-1 require endothelium-derived nitric oxide

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

Differential Regulation of Vascular Endothelial Growth Factor Expression by Peroxisome Proliferator-activated Receptors in Bladder Cancer Cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M309451200

21 January 2018

Identifiers

10.1074/JBC.M309451200

1 reference

Europe PubMed Central

4 December 2017

1 reference

Europe PubMed Central

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44639282&oldid=1769252007"